INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS)
CUSIP: 45828J103
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 48,324,727
- Total 13F shares
- 2,961,433
- Share change
- +982,735
- Total reported value
- $721,188
- Price per share
- $0.24
- Number of holders
- 26
- Value change
- +$231,320
- Number of buys
- 15
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 45828J103?
CUSIP 45828J103 identifies INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45828J103:
Top shareholders of INTS - INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
2.6%
|
1,237,113
|
$383,505 | +$113,015 | 30 Jun 2025 | |
| SAPIENT CAPITAL LLC |
13D/G
13F
|
Company |
3.9%
|
976,797
|
$312,575 | -$11,287 | 30 Jun 2025 | |
| Rothschild Wealth LLC |
13F
|
Company |
0.41%
|
199,316
|
$61,190 | — | 30 Jun 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.27%
|
130,072
|
$39,932 | — | 30 Jun 2025 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.23%
|
110,000
|
$33,770 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
72,813
|
$22,355 | — | 30 Jun 2025 | |
| Sigma Planning Corp |
13F
|
Company |
0.14%
|
69,167
|
$21,234 | — | 30 Jun 2025 | |
| Warberg Asset Management LLC |
13F
|
Company |
0.14%
|
68,400
|
$20,999 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
44,897
|
$13,783 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.08%
|
40,587
|
$12,460 | — | 30 Jun 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.08%
|
37,805
|
$11,606 | — | 30 Jun 2025 | |
| One Charles Private Wealth Services, LLC |
13F
|
Company |
0.07%
|
31,800
|
$9,763 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
24,553
|
$7,538 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.05%
|
24,904
|
$7,000 | — | 30 Jun 2025 | |
| QTR Family Wealth, LLC |
13F
|
Company |
0.04%
|
17,420
|
$5,348 | — | 30 Jun 2025 | |
| Stonebridge Financial Group, LLC |
13F
|
Company |
0.03%
|
16,525
|
$5,073 | — | 30 Jun 2025 | |
| EWA, LLC |
13F
|
Company |
0.03%
|
16,032
|
$4,922 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
15,000
|
$4,605 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
14,500
|
$4,452 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
14,024
|
$4,305 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
13,491
|
$4,142 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
13,700
|
$4,000 | — | 30 Jun 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
11,673
|
$3,584 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
9,234
|
$2,835 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
5,000
|
$1,535 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
500
|
$154 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
388
|
$119 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
100
|
$31 | — | 30 Jun 2025 | |
| Daniel Donovan |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Dr. Emer Leahy |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Mark A. Goldberg |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 | |
| Thomas I. H. Dubin |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 02 May 2025 |
Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.